Results 161 to 170 of about 3,591 (202)

Overview of the prevention and management of CINV.

The American journal of managed care, 2020
The prevention of chemotherapy-induced nausea and vomiting (CINV) is critically important in reducing morbidity and total healthcare costs in patients receiving emetogenic chemotherapy. The different types of CINV (ie, acute, delayed, anticipatory, breakthrough, and refractory) are controlled through various pathways and neurotransmitters, so the ...
openaire   +1 more source

Pharmacoeconomic considerations of tropisetron for prophylaxis and treatment of CINV and PONV

Expert Review of Pharmacoeconomics & Outcomes Research, 2003
Postoperative nausea and vomiting has been described as the big little problem in anesthesia, with the overall incidence after anesthesia using volatile anesthetics remaining between 20 and 30%. In patients who receive ambulatory surgery, postoperative nausea and vomiting may lead to delayed discharge or unplanned overnight admission to hospital which ...
Caroline D, Kratz, U, Seifart, Götz, Geldner, Leo Hj, Eberhart   +3 more
openaire   +2 more sources

Current Management of CINV (Preprint)

BACKGROUND Chemotherapy-induced nausea and vomiting (CINV) significantly impact cancer patients undergoing treatment, affecting their quality of life and treatment adherence. Despite advances in antiemetic therapy, CINV remains a challenge, necessitating ongoing research and development of effective ...
openaire   +1 more source

Palonosetron in allen CINV-Phasen effektiv

Info Onkologie, 2014
Palonosetron stellt als einziges Setron bei zytostatikainduzierter Ubelkeit und Erbrechen (CINV) in der akuten sowie der verzogerten Phase eine effektive Basisprophylaxe dar, wie aktuelle klinische Daten bestatigen.
openaire   +1 more source

Lange Halbwertszeit erleichtert CINV-Prophylaxe

Im Focus Onkologie, 2017
Nach wie vor leiden viele Patienten unter chemotherapieinduzierter Ubelkeit und Erbrechen (CINV). Dabei lassen sich diese Symptome durch eine leitliniengerechte Prophylaxe weitgehend verhindern, insbesondere, wenn moderne Antiemetika eingesetzt werden.
openaire   +1 more source

Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis

Supportive Care in Cancer, 2023
Eric Roeland, Lee S Schwartzberg
exaly  

Dronabinol an alternative to ondansetron for CINV

Inpharma Weekly, 2005
openaire   +2 more sources

Duration of CINV

2010
openaire   +1 more source

Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan

Expert Opinion on Pharmacotherapy, 2017
Yuki Kitano, Yoshihiro Kakeji, Eiji Oki
exaly  

Acute CINV

2010
openaire   +1 more source